193 related articles for article (PubMed ID: 10834325)
21. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
[TBL] [Abstract][Full Text] [Related]
22. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
23. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
24. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
25. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
[TBL] [Abstract][Full Text] [Related]
26. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
27. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.
Tergas AI; Buell-Gutbrod R; Gwin K; Kocherginsky M; Temkin SM; Fefferman A; Lengyel E; Yamada SD
Gynecol Oncol; 2012 Nov; 127(2):316-20. PubMed ID: 22835717
[TBL] [Abstract][Full Text] [Related]
28. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
[TBL] [Abstract][Full Text] [Related]
29. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
30. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
32. The effect of tamoxifen on the endometrium.
Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
[TBL] [Abstract][Full Text] [Related]
33. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
Barakat RR; Gilewski TA; Almadrones L; Saigo PE; Venkatraman E; Hudis C; Hoskins WJ
J Clin Oncol; 2000 Oct; 18(20):3459-63. PubMed ID: 11032585
[TBL] [Abstract][Full Text] [Related]
34. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
35. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.
Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E
J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378
[TBL] [Abstract][Full Text] [Related]
36. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058
[TBL] [Abstract][Full Text] [Related]
37. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
38. [Image of the month. Echographic image of endometrial polyp in a patient treated with tamoxifen].
van den Brûle F; Bawin L; Gaspard U
Rev Med Liege; 1998 Sep; 53(9):507-8. PubMed ID: 9834670
[No Abstract] [Full Text] [Related]
39. Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients.
Cohen I; Altaras MM; Shapira J; Tepper R; Rosen DJ; Cordoba M; Zalel Y; Figer A; Yigael D; Beyth Y
Int J Gynecol Pathol; 1996 Apr; 15(2):152-7. PubMed ID: 8786205
[TBL] [Abstract][Full Text] [Related]
40. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
